Matthias Diebold

Statistics

Publications

Citations

163

H-Index

Active since

2024

Affiliations

Medical University of Vienna(Current)

Matthias Diebold is an author at Medical University of Vienna specializing in antibody-mediated rejection therapy, immunotherapy after transplantation, and natural killer cell therapy.

Publications per year

2024–2024

Publications

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection

Katharina A. Mayer, Eva Schrezenmeier, Matthias Diebold et al. · New England Journal of Medicine · 2024 · 150 citations · Full text

Life Sciences, Immunology, Nephrology +15

Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study

Matthias Diebold, Hannes Vietzen, Martina Schatzl et al. · Transplantation · 2024 · 13 citations · Full text

Life Sciences, Genetics, Immunology +17

1–2 of 2